"Deoxyglucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.
| Descriptor ID |
D003847
|
| MeSH Number(s) |
D09.254.229
|
| Concept/Terms |
Deoxyglucose- Deoxyglucose
- 2-Deoxyglucose
- 2 Deoxyglucose
- 2-Deoxy-D-glucose
- 2 Deoxy D glucose
- 2-Desoxy-D-glucose
- 2 Desoxy D glucose
|
Below are MeSH descriptors whose meaning is more general than "Deoxyglucose".
Below are MeSH descriptors whose meaning is more specific than "Deoxyglucose".
This graph shows the total number of publications written about "Deoxyglucose" by people in this website by year, and whether "Deoxyglucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 4 | 4 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deoxyglucose" by people in Profiles.
-
Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program. Nat Genet. 2023 07; 55(7):1106-1115.
-
Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun; 11(6):1373-80.
-
Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production. Am J Physiol Endocrinol Metab. 2012 Jun 15; 302(12):E1550-9.
-
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther. 2011 Dec; 10(12):2350-62.
-
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res. 2011 Jul 01; 71(13):4585-97.
-
Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010 May 07; 395(3):395-400.
-
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010 Mar 15; 116(6):1454-61.
-
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene. 2009 Oct 22; 28(42):3689-701.
-
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol. 2003 Apr; 162(4):1283-91.
-
Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry. 2001 May 08; 40(18):5542-7.